Authors: Malsch, U Bliesath, H Bother, K Ramm, H Luhmann, R

Citation: U. Malsch et al., Monotherapy of Parkinson's disease with budipine - A randomised double-blind comparision to amantadine, F NEUR PSYC, 69(2), 2001, pp. 86

Authors: Bardhan, KD Cherian, P Bishop, AE Polak, JM Romanska, H Perry, MJ Rowland, A Thompson, M Morris, P Schneider, A Fischer, R Ng, W Luhmann, R McCaldin, B

Citation: Kd. Bardhan et al., Pantoprazole therapy in the long-term management of severe acid peptic disease - Clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies, AM J GASTRO, 96(6), 2001, pp. 1767-1776

Authors: Plein, K Hotz, J Wurzer, H Fumagalli, I Luhmann, R Schneider, A

Citation: K. Plein et al., Pantoprazole 20 mg is an effective maintenance therapy for patients with gastro-oesophageal reflux disease, EUR J GASTR, 12(4), 2000, pp. 425-432

Authors: Martinek, J Blum, AL Stolte, M Hartmann, M Verdu, EF Luhmann, R Dorta, G Wiesel, P

Citation: J. Martinek et al., Effects of pumaprazole (BY841), a novel reversible proton pump antagonist,and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection, ALIM PHARM, 13(1), 1999, pp. 27-34

Authors: Wurzer, H Schutze, K Bethke, T Fischer, R Luhmann, R Riesenhuber, C

Citation: H. Wurzer et al., Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen, HEP-GASTRO, 46(27), 1999, pp. 1809-1815

Authors: Kromer, W Horbach, S Luhmann, R

Citation: W. Kromer et al., Relative efficacies of gastric proton pump inhibitors: Their clinical and pharmacological basis, PHARMACOL, 59(2), 1999, pp. 57-77